Last ¥3,840 JPY
Change Today -25.00 / -0.65%
Volume 10.3K
4694 On Other Exchanges
Symbol
Exchange
Munich
Tokyo
OTC US
As of 2:00 AM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

bml inc (4694) Snapshot

Open
¥3,865
Previous Close
¥3,865
Day High
¥3,870
Day Low
¥3,830
52 Week High
05/26/14 - ¥4,070
52 Week Low
07/30/13 - ¥2,454
Market Cap
84.5B
Average Volume 10 Days
20.0K
EPS TTM
¥234.96
Shares Outstanding
22.0M
EX-Date
09/26/14
P/E TM
16.3x
Dividend
¥50.00
Dividend Yield
1.30%
Current Stock Chart for BML INC (4694)

Related News

No related news articles were found.

bml inc (4694) Related Businessweek News

No Related Businessweek News Found

bml inc (4694) Details

BML, Inc. provides laboratory testing and related services in Japan. It offers general laboratory tests, including biochemical and hematologic examinations; special laboratory tests, including RIA, cellular, immunological, and DNA analysis; microbiological tests for medical and pharmaceutical societies and organizations; and preventive medicine services. The company also provides various statistical data; operates Vita, a medical information quarterly journal; and builds in-house developed laboratory test information systems for hospitals. In addition, it offers a range of services in the food sanitation control and food processing environments comprising contract services for microorganism testing of raw materials, prepared foods, and processed foods; environmental hygiene testing of food processing facilities and kitchens; and microorganism testing services, as well as engages in the assessment of genetically modified organisms. Further, the company provides drinking water and waste water tests; work sanitation management support services, such as measurement of ethylene oxide gas, formaldehyde, organic solvents, and dust; environmental monitoring services, including measurement of indoor contaminants and other indoor environmental variables; and biological dioxin monitoring services. Additionally, it provides analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal disease; arranges and coordinates clinical research for pharmaceutical manufactures; offers consulting services for the approval of pharmaceuticals; and operates as a quality assurance unit for assurance of clinical research results. The company also provides investigative analysis services to pharmaceutical manufacturers; develops Omness, a clinical trial support system; and provides gene expression analysis and testing for genes that cause susceptibility to infectious diseases. BML, Inc. was founded in 1955 and is headquartered in Tokyo, Japan.

Founded in 1955

bml inc (4694) Top Compensated Officers

Senior Advisor and Director
Total Annual Compensation: ¥106.0M
Compensation as of Fiscal Year 2012.

bml inc (4694) Key Developments

BML Inc., Annual General Meeting, Jun 27, 2014

BML Inc., Annual General Meeting, Jun 27, 2014.

Bml Inc. Announces Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2014; Announces Year End Dividend for the Year Ended March 31, 2014, Payable on June 30, 2014; Provides Dividend Guidance for the End of Second Quarter of 2014 and Year End Dividend Guidance for Year Ending March 31, 2015; Provides Earnings Guidance for the First Half Year of Fiscal 2014 and for the Year Ending March 31, 2015

BML Inc. announced consolidated and non-consolidated earnings results for the year ended March 31, 2014. For the period, on consolidated basis, the company reported net sales of JPY 99,047 million compared to JPY 94,608 million a year ago. Operating income was JPY 8,188 million compared to JPY 6,637 million a year ago. Ordinary income was JPY 8,582 million compared to JPY 6,979 million a year ago. Net income was JPY 4,990 million or JPY 234.27 per diluted share compared to JPY 3,708 million or JPY 174.19 per diluted share a year ago. Return on equity was 9.4% compared to 7.5% a year ago. Cash flow from operating activities was JPY 10,931 million compared to JPY 9,792 million a year ago. Cash flows from operating activities increased JPY 1,138 million from the previous fiscal year. This was mainly due to an inflow increase of JPY 1,604 million in income before income taxes and minority interests. Income before income taxes and minority interests was JPY 8,568 million compared to JPY 6,963 million a year ago. Income before minority interests was JPY 5,348 million compared to JPY 3,977 million a year ago. Purchases of property, plant and equipment were JPY 2,225 million compared to JPY 2,215 million a year ago. Purchases of intangible assets were JPY 894 million compared to JPY 1,069 million a year ago. For the period, on non-consolidated basis, the company reported net sales of JPY 80,388 million compared to JPY 76,071 million a year ago. Operating income was JPY 5,198 million compared to JPY 4,670 million a year ago. Ordinary income was JPY 6,022 million compared to JPY 5,419 million a year ago. Net income was JPY 3,659 million or JPY 171.78 per diluted share compared to JPY 3,504 million or JPY 164.60 per diluted share a year ago. Return on equity was 9.4% compared to 7.5% a year ago. Cash flow from operating activities was JPY 10,931 million compared to JPY 9,792 million a year ago. The company announced year end dividend of JPY 30.00 per share for the fiscal 2013. The dividend will be payable on June 30, 2014. The company paid year end dividend of JPY 20.00 per share for the fiscal 2012. The company expects dividend of JPY 25.00 per share at the end of second quarter of fiscal 2014. The company expects year end dividend of JPY 35.00 per share for the fiscal 2014. For the first half year of 2014, the company expects net sales of JPY 51,040 million, operating income of JPY 4,780 million, ordinary income of JPY 4,960 million and net income of JPY 2,840 million or JPY 133.72 per share. For the year ending March 31, 2015, the company expects net sales of JPY 101,000 million, operating income of JPY 8,200 million, ordinary income of JPY 8,500 million and net income of JPY 4,900 million or JPY 230.72 per share.

BML Inc. to Report Fiscal Year 2014 Results on May 12, 2014

BML Inc. announced that they will report fiscal year 2014 results on May 12, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4694:JP ¥3,840.00 JPY -25.00

4694 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4694.
View Industry Companies
 

Industry Analysis

4694

Industry Average

Valuation 4694 Industry Range
Price/Earnings 16.8x
Price/Sales 0.8x
Price/Book 1.5x
Price/Cash Flow 17.3x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BML INC, please visit www.bml.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.